Companies: 10,795·Total market cap: $144.5T
Evolus, Inc.

Evolus, Inc.

EOLSNASDAQHealthcare● Active
$6.68
+$0.01(+0.15%)
Market Cap$439909737
P/E Ratio
52W High$10.62
52W Low$3.86

Evolus, Inc. (EOLS) Revenue

Annual & quarterly revenue history · segment & region breakdown

EOLS · revenue · updated Jun 8, 2026

Core revenue metrics

Evolus, Inc. trailing twelve-month (TTM) revenue is $0.30B, an increase of 11.61% year-over-year from $0.30B in FY2025.

TTM revenue
$0.30B
4-quarter sum · USD
YoY growth
+11.61%
vs FY2025 $0.30B
Price / sales
1.46×
mktCap ÷ TTM rev
Revenue per day
$1M
Est. TTM ÷ 365
Revenue / employee
$811K
372 employees
FY2025
$0.30B
FY2024
$0.27B
5Y CAGR
+24.4%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Evolus, Inc. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252015 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$0.30B+$0.03B+11.61%
2024-12-31$0.27B+$0.06B+31.76%
2023-12-31$0.20B+$0.05B+35.98%
2022-12-31$0.15B+$0.05B+49.10%
2021-12-31$0.10B+$0.04B+76.29%
2020-12-31$0.06B+$0.02B+61.89%
2019-12-31$0.03B+$0.03B
2018-12-31$0.00B+$0.00B
2017-12-31$0.00B+$0.00B
2016-12-31$0.00B+$0.00B
EOLS revenue by year · EOLS revenue history · EOLS annual revenue data

Revenue breakdown

Segment & Geography
By business segment
Total$0.30B
$0.29B99.3%
$0.00B0.7%
By geography
No segment data available for this period.
Data from Evolus, Inc. annual 10-K filing · FY ending 2025-12-31
EOLS revenue breakdown · EOLS revenue by segment · EOLS revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Evolus, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Evolus, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Evolus, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

EOLS revenue · 4 questions

EOLS's trailing twelve-month (TTM) revenue is $0.30B. That is an increase of 11.61% year-over-year from $0.30B in FY2025.

EOLS revenueEOLS annual revenuewhat is EOLS revenueEOLS TTM revenue

Source: FMP · Evolus, Inc. SEC filings · GAAP · Evolus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026